Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)

NCT00172172 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00172172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00172172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
January 10, 2004
Completion date
March 11, 2005
Enrollment
374 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis